Covid-19 Update April 24, 2020

Today is a great day and time for a new beginning!  On April 24, 2020 the American Society for Reproductive Medicine provided guidance on how fertility practices should proceed during the Covid-19 pandemic.  We know many of you have been eagerly awaiting the opportunity to move forward in your fertility journey.

We are pleased to say that we will be seeing patients in the office for fertility evaluations and treatments starting May 1, 2020.  Patients who would like to have their new patient consultation or follow-up consultation conducted by are still able to do schedule a telemedicine visit if they choose.

Upon arrival to our office we will provide all measures to make sure you have a safe visit including:

  • Limiting patients in the office to one patient or couple every hour
  • Eliminating overlap of patients visits as much as possible
  • Providing each patient with their own private waiting room
  • Providing a mask to patients who do not bring one to their appointment
  • Providing hand sanitizer
  • Minimizing the number of staff that you have contact with during your appointment
  • Providing our staff with the most current education, practices and PPE for your safety
  • Use of electronic communication for collecting and sharing information
  • Education about your personal safety and safety during pregnancy
  • Contactless check-in, check-out and payment
  • Temperature & symptom screening at each appointment
  • Providing testing for Covid-19 as it becomes available

 

We know that you probably have many questions related to Covid-19 and undergoing fertility treatments.  At each appointment that you attend we will provide you with the most current information available as it is constantly evolving.  We are constantly reviewing and practicing the latest recommendations from major medical societies & government agencies including the:

  • American Society for Reproductive Medicine (ASRM)
  • Society for Assisted Reproductive Technology (SART)
  • American College of Obstetricians & Gynecologists (ACOG)
  • Society for Maternal Fetal Medicine (SMFM)
  • Center for Disease Control (CDC)
  • Food & Drug Administration (FDA)
  • Occupational Safety and Health Administration (OSHA)
  • Texas Medical Board (TMB)

 

We advise you to continue to practice healthy habits as you prepare for pregnancy which includes a healthy diet, regular exercise, avoiding smoking and limiting alcohol intake.  Please make sure that as life is slowly returning to normal that you continue to practice safe social distancing, limit trips to public spaces, wear a cloth mask (at a minimum) in public and wash your hands frequently for at least 20 seconds each time.

Prior to your appointment, if you are experiencing a temperature greater than 100.0 F, fever or chills, coughing, body aches or abdominal symptoms prior to your appointment please let us know beforehand.   We may request that you conduct a telemedicine appointment and see your primary care provider prior to coming to the office again.

We look forward to seeing you in person (or video) soon!  Take care and be safe!

 


COVID-19 APRIL 14, 2020 UPDATE

We hope all of you are doing well and maintaining a positive outlook.  You are all in our thoughts during this challenging time and we understand that the current Covid-19 adds another level of uncertainty to fertility treatment.  We wanted to provide you the most recent update from the American Society for Reproductive Medicine (ASRM) from April 14, 2020 but also to let you know that discussions are actively taking place within our community as to how to begin evaluating and treating fertility patients in the office again.  Currently ASRM recommend limiting fertility treatments and diagnostic procedures to emergencies only until they reevaluate on April 27, 2020.  Their prior recommendations are to remain in place as previously stated:

  1. Suspending initiation of new treatment cycles, including ovulation induction, intrauterine inseminations (IUIs), in vitro fertilization (IVF) including retrievals and frozen embryo transfers, as well as non-urgent gamete cryopreservation.
  2. Strongly considering cancellation of all embryo transfers whether fresh or frozen.
  3. Continuing to care for patients who are currently “in-cycle” or who require urgent stimulation and cryopreservation.
  4. Suspending elective surgeries and non-urgent diagnostic procedures.
  5. Minimizing in-person interactions and increasing utilization of telehealth.

Please do not hesitate to reach out to us if you have any questions or concerns about the above guidelines, about your care or anything else on your mind.

Thank you,

The Inovi Fertility & Genetics Institute Team


Covid-19 March 18, 2020 Update

Dear Patients and Friends of Inovi Fertility & Genetics Institute,

As you know Covid-19 is having a profound affect worldwide and in our daily lives here in the United States and Houston. As the number of cases grows and the situation evolves rapidly, we are urging everyone to be safe, take the recommended precautions and avoid unnecessary activity in public spaces that could result in exposure to Covid-19.

According to the Center for Disease Control, the best way to avoid getting sick is to avoid exposure to those who have the Covid-19 or are exhibiting symptoms (coughing or sneezing, fever and/or flu-like symptoms) that suggests they may have the virus. The virus is usually spread through respiratory droplets (coughing or sneezing) or close personal contact (standing within 6 feet of others). It is also recommended that you wash your hands frequently for at least 20 seconds each time, use hand sanitizer containing at least 60% alcohol and avoid touching your face, eyes or nose.

On March 17, 2020 the American Society for Reproductive Medicine (ASRM), the largest fertility society nationally and internationally, released a statement with recommendations regarding fertility practices. They recommended that any non-urgent evaluations (ultrasound, HSG) or procedures be postponed until further notice. The procedures include ovulation induction with Clomid or Letrozole, insemination, IVF procedures (egg retrieval or embryo transfers), and surgeries performed in the office or hospital. In the interest of the safety of our patients and staff, in order to limit their exposure to Covid-19, we will be limiting patient care and consultations to telemedicine (phone calls). Follow up recommendations will be released by ASRM before the end of March and we will update our patients accordingly. We respect the recommendations of our society and strive to provide fertility care at the highest level while providing the best care for our patients. We look forward to resuming normal practices soon and hope that all of you stay safe. Your safety is paramount to us.

Start your journey

get in touch with us